| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |